[ad_1]
LONDON (Reuters) – The winners of the 2018 Nobel Prize in Medicine, James Allison, and Japan's Tasco Hongo are expected to make significant progress in cancer treatment in the coming decades, the British daily The Daily Mail reported on Monday. The disease is unlikely to be eradicated, the scientists said.
Alison and Hongo made the final assessment at a press conference held on Thursday, December 6, 2018, several days before receiving a million dollar award. Last October, the Nobel Laureates in medicine announced their work on immunotherapy: activate the body's natural defense system to fight tumors.
The Russian website said that in an interview with the winners, they said that this assessment was fair for many cancers, which can not be eliminated. However, many cancers can be prevented by stopping smoking, improving diets and physical activity and increasing the number of people on HPV vaccine. However, US scientist Allison confirmed, "The world will never be richer in HPV vaccines, without cancer."
Japanese scientist Hongo, who will receive the award with Allison in Stockholm on Monday, December 10, 2018, said he expects that immunotherapy will eventually be used against most cancers, as well as radiotherapy or chemotherapy. . Hongo believes that cancer can be effectively stopped even if the tumor can not be completely eradicated while surviving some tumors. Although immunotherapy is a major breakthrough in cancer treatment, the costs are high, with treatments estimated to be over $ 100,000.
In her interview with the Daily Mail, Shelley Trowerger, deputy director of the population science department at the Moffitt Cancer Center, said, "Many cancers can be totally prevented by slightly changing lifestyle. on other types and better control them. "
[ad_2]
Source link
